LifeMD Weight Loss Review: Membership Model, NovoCare Pricing, and the Compounding Pivot (May 2026)

LifeMD is one of the louder names in telehealth weight management. It trades on the NASDAQ, has formal agreements with both Novo Nordisk and Eli Lilly, and handles prior authorisation in-house for insured patients. For certain patients those credentials are worth a lot.

They are also worth scrutiny. LifeMD charges a monthly program fee on top of the drug cost, and the two-line bill has surprised more than a few new members. This review makes both lines visible before you sign up.

Everything here is built from LifeMD’s published program and pricing pages, NovoCare’s published pharmacy pricing, company press releases (including SEC-filed 8-Ks announcing the Novo and Lilly partnerships), and independent assessments from Healthline, TeleHealth Ally, and Trimi Health. We have not completed a hands-on sign-up; a dated update will be added when we do. Corrections to [email protected].

At a Glance

Prices verified May 2026 from lifemd.com/weight-management and novocare.com. Drug pricing reflects NovoCare Savings Offer terms; eligibility conditions apply. Always verify current pricing at source before enrolling.

What LifeMD Is

LifeMD started life in 2019 as Conversion Labs, a DTC subscription health company that sold products through Rex MD, its men’s health sub-brand. It rebranded as LifeMD in 2021 as it expanded into primary telehealth care. The weight management program is one of several condition-specific offerings on a platform that also covers mental health, women’s health, and primary care.

The company is publicly listed on the NASDAQ under the ticker LFMD. That matters in a category full of private-equity-backed startups because it means LifeMD files 10-K annual reports, holds earnings calls, and has audited financials. Its 2025 revenue was reported at $194.1 million, a 25% year-over-year increase, driven largely by the GLP-1 program ramp.

The weight management operation runs on a membership model. You pay a monthly program fee to LifeMD for clinical access — consultations, lab coordination, coaching, and (for insured patients) prior authorisation management. The drug itself is billed separately, either through your insurance, through NovoCare Pharmacy for Novo Nordisk products, or through LillyDirect for Zepbound.

This two-part structure is different from single-purpose GLP-1 platforms that bundle a clinical fee into an all-in monthly price. It means LifeMD’s headline membership number ($149/month) is not the total cost. The total cost is the program fee plus whatever the drug costs.

Rex MD, LifeMD’s men’s health brand, is a separate product line focused on erectile dysfunction and testosterone. It is unrelated to the Weight Management Program.

Pricing Reality

LifeMD charges two separate monthly amounts. Both are required if you are using the platform for GLP-1 treatment.

Layer 1: The Weight Management Program Fee

• First month: $75
• Ongoing: $149/month
• With a PPO insurance plan: as low as $29/month (reported by TeleHealth Ally; verify at enrollment)

This fee covers provider consultations, prescription management, lab work (if not completed within the previous 12 months), coaching, weight tracking tools, and — for insured patients — insurance navigation and prior authorisation handling.

Layer 2: Medication Costs

Drug costs are billed separately and depend on which medication you use, whether you have insurance, and which dose you are on.

Introductory Wegovy pen pricing applies to new NovoCare Pharmacy patients only. The $199/mo introductory offer covers two monthly fills (0.25 mg and 0.5 mg doses). Terms set by Novo Nordisk, not LifeMD; eligibility conditions apply. Source: novocare.com, verified May 2026.

Total All-In (Self-Pay Injectable)

• Month 1: $75 (program fee) + $199 (Wegovy intro) = $274
• Month 3+ (standard dose): $149 (program fee) + $349 (Wegovy) = $498
• Higher doses: up to $548–$648/month

For insured patients, the drug cost can drop to near zero if prior authorisation is approved, leaving the $149/month (or $29/month) program fee as the primary ongoing cost.

LifeMD Plus — A Separate Product

LifeMD also sells a $19/month general telehealth membership called LifeMD Plus that covers urgent and primary care consultations. It is distinct from the Weight Management Program. You do not need LifeMD Plus to access the GLP-1 program, and holding LifeMD Plus does not reduce your program fee. The two products serve different purposes.

NovoCare Integration

LifeMD is one of Novo Nordisk’s officially recognised telehealth partners through NovoCare, Novo Nordisk’s specialty pharmacy channel. The partnership was announced in April 2025 alongside Ro and Hims & Hers, in the weeks immediately following the FDA’s declaration that the semaglutide shortage was resolved.

In practical terms, the integration works like this: a LifeMD provider writes a Wegovy or Ozempic prescription, and eligible patients fill it through NovoCare Pharmacy at NovoCare’s published cash-pay prices. For most patients that means home delivery directly from NovoCare. The pricing you see — $349/month for standard-dose Wegovy pen — is set by Novo Nordisk through NovoCare, not by LifeMD. LifeMD does not add a markup.

In January 2026, LifeMD expanded the collaboration to include the newly FDA-approved Wegovy pill (oral semaglutide), which became available to eligible patients through NovoCare at $149/month for the starting dose. That positions LifeMD as one of the first platforms to offer the oral formulation to self-pay patients at scale.

Novo Nordisk also launched a multi-month subscription program in March 2026 across its telehealth partners — including LifeMD — designed to let patients lock in rates over a three- or six-month window. That program is expected to save qualifying patients up to $1,200 a year on injectable Wegovy compared to monthly pay-as-you-go pricing.

For context on what the NovoCare model means if you want to bypass a platform entirely, see our explainer at /cost/novocare-wegovy-enrollment.

The Compounding Pivot

LifeMD offered compounded GLP-1 medications while the FDA shortage exemptions were in effect. Like most telehealth platforms, it sourced from FDA-registered 503B outsourcing facilities. Unlike platforms that leaned entirely into the compounding model, LifeMD had been building its branded-drug infrastructure through Novo Nordisk and Eli Lilly relationships ahead of the regulatory change.

The key dates: the FDA declared the tirzepatide shortage resolved on October 2, 2024, and the semaglutide shortage resolved on February 21, 2025. All 503A and 503B enforcement-discretion windows closed by May 22, 2025. By the time those windows closed, LifeMD had already formalised its Novo partnership (April 2025) and could route patients to branded Wegovy rather than scrambling to find a new supply model.

LifeMD’s current position is explicit: it no longer offers compounded GLP-1s and advises patients on compounded formulations to speak with their provider about transitioning to branded options. The company publishes a comparison page making the case for brand-name over compounded medications — which, given that branded is now the only legal pathway for most patients under §503 rules, functions as post-hoc positioning as much as patient education.

The compounding exit was earlier and less turbulent than some competitors. For a full map of which platforms still operate legal compounding pathways (limited to §503A(b)(1)(D) patient-specific preparations), see /regulatory/fda-compounding-cliff and the live provider tracker.

Sign-Up and Intake

The LifeMD sign-up starts with an online health questionnaire. Questions cover weight history, medical history, current medications, and lifestyle factors. A licensed provider reviews the intake asynchronously and, if appropriate, initiates a prescription or schedules a video consultation.

For cash-pay patients, LifeMD reports same-day prescriptions are possible in qualifying cases. The company promotes same-day video consultation availability as a differentiator over platforms with longer scheduling windows.

Lab work is included in the program fee if you have not had the relevant tests within the prior 12 months. LifeMD routes labs through Quest Diagnostics and Labcorp, both of which have broad national networks. For patients new to GLP-1 treatment, this bundled lab step is useful; for patients transferring from another platform with recent labs, it may be redundant but is still required for the LifeMD record.

For insured patients, the intake triggers a prior authorisation workflow. LifeMD’s in-house PA team manages letters of medical necessity, appeals, and insurer correspondence — a real operational benefit that compares favourably with platforms that outsource PA or leave it to the patient. PA timelines still depend on the insurer and can take two to four weeks or longer.

Support Quality

LifeMD provides 24/7 provider messaging through the patient portal and the LifeMD app. Scheduled video visits with a provider are available; outside of the bundled consultations, these are billed separately at $50 per session for cash-pay patients.

Ongoing coaching is included in the program fee. The coaching component covers weight tracking, habit-building, and periodic wellness check-ins rather than one-on-one clinical management.

The platform app also includes habit tracking, progress tools, and access to partner fitness and gym resources. These are positioned as supplementary supports rather than the core clinical offering.

Consumer complaints on file with the Better Business Bureau and reported in review aggregators cluster around billing transparency — specifically around the two-part pricing structure, where some patients report surprise at seeing both the program fee and the drug billed as separate charges. The company has added a visible cancel-anytime option in the patient portal, which addresses the cancellation friction complaints common to subscription health platforms. Independent reviewers rate the clinical support quality positively; the support complaints are predominantly administrative rather than clinical.

Cancellation

LifeMD operates a month-to-month subscription with no long-term contract. You can cancel through the patient portal (Billing & Card → Cancel/Pause Subscription) or by emailing [email protected] at any time.

There are two distinct cancellation considerations:

1. The program membership fee. Monthly fees already billed are non-refundable. After cancellation, access continues through the end of the paid period; no further charges are taken.

2. The prescription. Cancelling the LifeMD membership does not automatically cancel an active prescription. If you have an active Wegovy prescription filled through NovoCare, you will need to contact NovoCare separately to manage refills. The medication relationship and the membership are separate.

The 10% body-weight money-back guarantee is structured to function as a retention mechanism rather than a no-questions-asked refund. Eligibility requires 12 months of continuous enrollment (self-pay only), weekly weight updates without gaps longer than 10 days, attendance at all consultations, completion of all lab work, and a clean billing account. Refunds are issued net of deductions for clinical costs incurred. Medication costs are excluded entirely.

Best For / Not For

LifeMD works well for:

• Insured patients with a commercial PPO plan who want in-house prior authorisation handling. This is LifeMD’s clearest differentiator.
• Patients who want access to both semaglutide and tirzepatide, plus the Wegovy oral pill, on a single platform.
• Patients who value the accountability of a NASDAQ-listed company with audited financials and regulatory disclosure requirements.
• Patients who want same-day or rapid-response provider access rather than asynchronous-only care.

LifeMD is a harder fit for:

• Self-pay patients on a tight budget. At $498–$648/month all-in (program fee + standard-dose Wegovy), it is among the more expensive self-pay options. The drug cost is identical to other NovoCare partners; LifeMD’s program fee is the differentiating cost.
• Patients seeking non-branded compounded GLP-1s — these are not available on the platform.
• Medicare or Medicaid patients — LifeMD does not support government insurance for the GLP-1 program as of May 2026.
• Patients who want a single, fully bundled all-in monthly price without two separate billing lines.

LifeMD vs. Ro: Two NovoCare Partners, One Key Difference

Both LifeMD and Ro operate as active Novo Nordisk NovoCare telehealth partners. Both prescribe branded Wegovy at NovoCare’s published cash-pay prices. Both charge a monthly platform fee on top of drug costs. The drug pricing is identical because both route through the same NovoCare channel. The meaningful differences are structural.

The practical decision rule: if you have commercial PPO insurance and want a platform that will fight the prior authorisation battle for you, LifeMD has a structural advantage. If you are self-pay and primarily looking for the cheapest monthly membership fee alongside NovoCare pricing, the two platforms are functionally equivalent — the $4/month program fee difference is not a meaningful differentiator.

For a broader cross-platform comparison, see /providers/compare. For the full Ro review, see /providers/ro-body-review. For a breakdown of what NovoCare actually costs without any platform layer, see /cost/novocare-wegovy-enrollment and /cost/cheapest-place-to-get-wegovy.

What Reddit and Patient Discussions Reveal

Direct LifeMD-specific Reddit discussions are sparse compared to the volume of content on Hims, Ro, and independent prescriber options. Three patterns emerge from available forum and review data.

First, insured patients who successfully navigate prior authorisation through LifeMD report strong satisfaction. The PA team’s in-house handling converts a process that most patients find opaque and exhausting into something managed on their behalf. Patients who would be managing PA letters and appeals themselves without a telehealth platform see real value in this.

Second, self-pay patients who did not fully absorb the two-part pricing structure at sign-up report frustration when the second bill arrives. The program fee and drug cost appear as two separate charges, and the gap between the advertised “starting at $199” Wegovy headline and the actual monthly total has generated complaints about pricing transparency. LifeMD’s pricing pages do disclose both costs, but the two-line structure requires careful reading.

Third, the compounding exit has not generated significant patient backlash, which suggests LifeMD’s patient base skewed more toward insured and branded-drug-eligible patients from the start. Platforms that built their patient volume on compounded semaglutide at $99–$199/month have faced harder transitions as those patients lose access to lower-cost options.

Frequently Asked Questions

How much does LifeMD weight loss cost per month in 2026?

There are two separate charges. The Weight Management Program fee is $75 for the first month, then $149/month. Medication is billed separately. Wegovy pen starts at $199/month introductory for the two lowest doses (through June 30, 2026), then $349/month for standard doses. Zepbound vials are $349/month via LillyDirect. The Wegovy pill starts at $149/month. Total first-month all-in with Wegovy pen: around $274. Ongoing steady-state for a self-pay injectable patient: $498–$648/month.

Does LifeMD still offer compounded semaglutide?

No. LifeMD transitioned fully to branded FDA-approved medications in 2025. The FDA declared the semaglutide shortage resolved in February 2025, closing the shortage-exemption pathway for compounding. All 503A and 503B enforcement windows closed by May 22, 2025. LifeMD’s Novo Nordisk partnership for branded access was formalised in April 2025 — the pivot was early relative to the enforcement deadline.

What is LifeMD Plus and is it required?

LifeMD Plus is a separate $19/month general telehealth membership covering urgent and primary care, with video visits from $50 and messaging visits from $20. It is not required to access the Weight Management Program. The two products are billed independently and serve different purposes.

How does LifeMD’s NovoCare partnership work?

LifeMD is a Novo Nordisk NovoCare recognised telehealth partner. When a LifeMD provider prescribes Wegovy or Ozempic, eligible patients fill through NovoCare Pharmacy at NovoCare’s published prices. LifeMD does not mark up the drug price. The introductory $199/month offer is a NovoCare Savings Offer available to new NovoCare patients only; eligibility conditions are set by Novo Nordisk.

Does LifeMD accept insurance for GLP-1 medications?

LifeMD accepts most major commercial PPO plans and manages prior authorisation in-house. Medicare and Medicaid are not supported for the GLP-1 program as of May 2026. The monthly program fee ($149/mo) is a cash-pay charge that does not count toward your insurance deductible regardless of drug coverage.

Can I cancel my LifeMD membership?

Yes — anytime, through the patient portal (Billing & Card → Cancel/Pause Subscription) or by emailing [email protected]. Monthly fees already billed are non-refundable. Cancelling your LifeMD membership does not automatically cancel an active prescription; manage active NovoCare prescriptions directly with NovoCare.

How does LifeMD compare to Ro Body?

Both are active NovoCare partners charging a program fee plus NovoCare drug prices. The meaningful difference: LifeMD accepts commercial PPO insurance and handles prior authorisation in-house; Ro operates cash-pay only for the membership and does not support government insurance. For self-pay patients, the two platforms are functionally equivalent — program fees ($149/mo LifeMD vs $145/mo Ro) are near-identical at steady state. See /providers/ro-body-review for the full Ro assessment and /providers/hims-vs-ro for a broader market comparison.

Is LifeMD a legitimate company?

LifeMD is a publicly traded US company (NASDAQ: LFMD) with $194.1 million in 2025 revenue. It holds formal commercial agreements with Novo Nordisk and Eli Lilly and operates licensed providers across all 50 states. Consumer complaints about billing transparency are on record, primarily related to the two-part pricing structure. The company has added a visible cancel-anytime portal option. Reading the cancellation and refund terms before enrolling — particularly the conditions on the 10% money-back guarantee — is recommended.